KFDA to make public screening guideline for superbiosimilars in September

The Korea Food and Drug Administration said it will form a working group to formulate a new guideline for biological products, the so-called superbiosimilars or biovectors as early as in September.

“The guideline will be a cornerstone to facilitate the local development of biological product,” a KFDA official said.

Headded that the biological market segment is widely expected to become a ...